Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Turbine
Budapest, Hungaryturbine.ai ↗
- Ownership
- Private
- Employees
- ~82
- Development stage
- Preclinical
01
Overview
Turbine’s Simulated Cell™ platform enables large-scale, interpretable in silico experiments that model cancer at the molecular level. This allows rapid hypothesis testing, target identification, drug combination design, biomarker discovery, and patient stratification. Their approach has been validated through partnerships with major pharma companies such as Bayer and AstraZeneca. No direct clinical results from proprietary drugs have been published as of June 2025.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeAntibody-drug conjugate
- Industry
- Drug Discovery Services
02
Partnerships
Beyond the preview
Go deeper on Turbine.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Turbine.